Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/1994

TDMS Study 05180-07 Pathology Tables

NTP Experiment-Test: 05180-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          GALLIUM ARSENIDE                                     Date: 03/09/99
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 14:17:25

                                                      2 YEAR CHRONIC MICE




       Facility:  Battelle Northwest

       Chemical CAS #:  1303-00-0000

       Lock Date:  04/11/97

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 05180-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          GALLIUM ARSENIDE                                     Date: 03/09/99  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 14:17:25  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        CONTROL      0.1          0.5          1.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 


  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                11           11           16           11                                     
    Natural Death                                      3            3            2           10                                     
    Accidently Killed                                               2            1                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                36           34           31           29                                     

  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (50)         (49)         (50)                                   
      Inflammation, Suppurative                                     1 (2%)                                                          
   Gallbladder                                        (47)         (45)         (45)         (41)                                   
      Degeneration, Hyaline                                         1 (2%)                                                          
      Epithelium, Hyperplasia                          1 (2%)                                                                       
   Intestine Large, Cecum                             (48)         (49)         (50)         (46)                                   
      Hemorrhage                                                    1 (2%)                                                          
      Infiltration Cellular, Mast Cell                                           1 (2%)                                             
   Intestine Small, Jejunum                           (48)         (47)         (49)         (43)                                   
      Peyer's Patch, Hyperplasia                       2 (4%)       1 (2%)                                                          
   Intestine Small, Ileum                             (48)         (47)         (49)         (45)                                   
      Hemorrhage                                                    1 (2%)                                                          
      Inflammation                                                  1 (2%)       1 (2%)                                             
      Peyer's Patch, Hyperplasia                       1 (2%)                    2 (4%)       1 (2%)                                
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                                                             1 (2%)                                
      Clear Cell Focus                                                           1 (2%)                                             
      Clear Cell Focus, Multiple                       1 (2%)                                                                       
      Degeneration, Fatty                              1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
      Eosinophilic Focus                               3 (6%)      13 (26%)     10 (20%)     10 (20%)                               
      Eosinophilic Focus, Multiple                     2 (4%)       2 (4%)       1 (2%)       4 (8%)                                
      Hematopoietic Cell Proliferation                 3 (6%)       4 (8%)       5 (10%)      5 (10%)                               
      Hemorrhage                                                    1 (2%)                                                          
      Hyperplasia, Lymphoid                            1 (2%)       3 (6%)       1 (2%)                                             
      Inflammation                                     3 (6%)       1 (2%)       1 (2%)                                             
      Necrosis                                         3 (6%)       4 (8%)       7 (14%)      5 (10%)                               
      Pigmentation, Hemosiderin                        1 (2%)                                                                       
      Bile Duct, Cyst                                  1 (2%)                                                                       
      Bile Duct, Degeneration, Hyaline                 1 (2%)                                                                       
      Oval Cell, Hyperplasia                           1 (2%)       1 (2%)                                                          
      Serosa, Inflammation                                                                    1 (2%)                                
   Mesentery                                          (8)          (9)          (16)         (13)                                   
      Hemorrhage                                       1 (13%)                                1 (8%)                                

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05180-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          GALLIUM ARSENIDE                                     Date: 03/09/99  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 14:17:25  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        CONTROL      0.1          0.5          1.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Inflammation, Chronic                            1 (13%)                                1 (8%)                                
      Inflammation, Suppurative                                                  2 (13%)                                            
      Fat, Necrosis                                    4 (50%)      9 (100%)    13 (81%)     11 (85%)                               
   Pancreas                                           (50)         (50)         (50)         (49)                                   
      Atrophy                                          5 (10%)     10 (20%)     11 (22%)      2 (4%)                                
      Cytoplasmic Alteration                           1 (2%)       1 (2%)       2 (4%)       1 (2%)                                
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
      Duct, Cyst                                                    2 (4%)       2 (4%)                                             
   Stomach, Forestomach                               (49)         (50)         (50)         (49)                                   
      Hemorrhage                                       1 (2%)                                                                       
      Ulcer                                            1 (2%)       1 (2%)                    2 (4%)                                
      Epithelium, Hyperplasia                          2 (4%)       6 (12%)      1 (2%)       2 (4%)                                
   Stomach, Glandular                                 (49)         (50)         (50)         (48)                                   
      Inflammation, Suppurative                                     2 (4%)                                                          
      Ulcer                                                         1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                  49 (98%)     48 (96%)     47 (94%)     47 (94%)                               
      Artery, Inflammation                                          1 (2%)       1 (2%)       1 (2%)                                
      Atrium, Thrombosis                                                                      1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (49)                                   
      Hematopoietic Cell Proliferation                 1 (2%)       1 (2%)       1 (2%)                                             
      Hypertrophy                                      5 (10%)      5 (10%)      7 (14%)      7 (14%)                               
      Capsule, Hyperplasia                                                                    1 (2%)                                
   Adrenal Medulla                                    (50)         (49)         (50)         (49)                                   
      Hyperplasia                                      1 (2%)       2 (4%)       1 (2%)       2 (4%)                                
   Islets, Pancreatic                                 (50)         (50)         (50)         (48)                                   
      Hyperplasia                                      1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
   Pituitary Gland                                    (46)         (48)         (50)         (47)                                   
      Pars Distalis, Hyperplasia                      16 (35%)     20 (42%)     20 (40%)      9 (19%)                               
   Thyroid Gland                                      (50)         (50)         (50)         (49)                                   
      Follicular Cell, Hyperplasia                    10 (20%)     17 (34%)     14 (28%)     12 (24%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05180-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          GALLIUM ARSENIDE                                     Date: 03/09/99  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 14:17:25  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        CONTROL      0.1          0.5          1.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Ovary                                              (49)         (50)         (50)         (46)                                   
      Angiectasis                                      2 (4%)                    2 (4%)                                             
      Atrophy                                          3 (6%)       2 (4%)       2 (4%)                                             
      Cyst                                            18 (37%)     17 (34%)     23 (46%)     15 (33%)                               
      Hemorrhage                                                                 1 (2%)                                             
      Hyperplasia                                                   1 (2%)                                                          
      Interstitial Stromal Tumor                       1 (2%)                                                                       
      Thrombosis                                                                 1 (2%)                                             
      Germinal Epithelium, Hyperplasia                              1 (2%)                                                          
   Uterus                                             (49)         (50)         (50)         (50)                                   
      Angiectasis                                      1 (2%)       1 (2%)       2 (4%)                                             
      Hematocyst                                       1 (2%)                                                                       
      Hydrometra                                       2 (4%)       4 (8%)       3 (6%)       4 (8%)                                
      Hyperplasia, Cystic                              2 (4%)       2 (4%)       2 (4%)       3 (6%)                                
      Inflammation, Suppurative                                     1 (2%)       1 (2%)                                             
      Thrombosis                                                                              1 (2%)                                
      Endometrium, Hyperplasia                         1 (2%)                                                                       
      Myometrium, Hyperplasia                          2 (4%)                    2 (4%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      2 (4%)       1 (2%)       2 (4%)       1 (2%)                                
   Lymph Node                                         (4)          (8)          (5)          (6)                                    
      Angiectasis                                      2 (50%)      1 (13%)      2 (40%)                                            
      Renal, Angiectasis                                            1 (13%)                                                         
      Renal, Hyperplasia                                            1 (13%)                   1 (17%)                               
   Lymph Node, Bronchial                              (39)         (43)         (42)         (42)                                   
      Hyperplasia                                     10 (26%)     12 (28%)     13 (31%)     23 (55%)                               
   Lymph Node, Mandibular                             (35)         (37)         (43)         (43)                                   
      Hyperplasia                                      1 (3%)                    1 (2%)       2 (5%)                                
   Lymph Node, Mesenteric                             (49)         (49)         (50)         (47)                                   
      Hyperplasia                                      3 (6%)       3 (6%)       5 (10%)      6 (13%)                               
   Lymph Node, Mediastinal                            (40)         (43)         (49)         (45)                                   
      Hematopoietic Cell Proliferation                                           2 (4%)                                             
      Hyperplasia                                      5 (13%)      3 (7%)       6 (12%)      8 (18%)                               
   Spleen                                             (50)         (50)         (50)         (49)                                   
      Hematopoietic Cell Proliferation                23 (46%)     22 (44%)     22 (44%)     28 (57%)                               
      Hyperplasia, Histiocytic                                                                1 (2%)                                
      Hyperplasia, Lymphoid                           20 (40%)     12 (24%)     18 (36%)      7 (14%)                               
      Capsule, Inflammation                            1 (2%)                                                                       
   Thymus                                             (43)         (47)         (43)         (44)                                   
      Angiectasis                                                                1 (2%)                                             
      Hyperplasia, Lymphoid                            1 (2%)                                 1 (2%)                                
____________________________________________________________________________________________________________________________________

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05180-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          GALLIUM ARSENIDE                                     Date: 03/09/99  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 14:17:25  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        CONTROL      0.1          0.5          1.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (50)         (50)         (49)                                   
      Hyperplasia                                      4 (8%)       4 (8%)       2 (4%)       3 (6%)                                
   Skin                                               (50)         (50)         (50)         (50)                                   
      Subcutaneous Tissue, Hemorrhage                               2 (4%)       2 (4%)                                             
      Subcutaneous Tissue, Inflammation                             1 (2%)       1 (2%)                                             
      Subcutaneous Tissue, Inflammation,                                                                                            
          Granulomatous                                                                       1 (2%)                                
      Subcutaneous Tissue, Mineralization              1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Fibrous Osteodystrophy                          21 (42%)     24 (48%)     14 (28%)     18 (36%)                               
      Maxilla, Fracture                                             1 (2%)       1 (2%)                                             
   Skeletal Muscle                                    (1)          (2)          (1)          (1)                                    
      Hemorrhage                                                    1 (50%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Cyst Epithelial Inclusion                                                               1 (2%)                                
      Gliosis                                                                    1 (2%)                                             
      Hemorrhage                                                    1 (2%)                    1 (2%)                                
      Meninges, Infiltration Cellular, Mononuclear                                                                                  
          Cell                                         2 (4%)       5 (10%)      3 (6%)       3 (6%)                                
   Spinal Cord                                        (1)          (1)          (1)                                                 
      Hyperplasia, Lymphoid                            1 (100%)                  1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (50)         (50)         (50)         (50)                                   
      Inflammation, Suppurative                        2 (4%)       2 (4%)       2 (4%)       1 (2%)                                
      Squamous Epithelium, Hyperplasia                11 (22%)      9 (18%)      7 (14%)      7 (14%)                               
   Lung                                               (50)         (50)         (50)         (50)                                   
      Congestion                                       1 (2%)                                                                       
      Hemorrhage                                       9 (18%)      6 (12%)      5 (10%)      5 (10%)                               
      Infiltration Cellular, Histiocyte                2 (4%)      13 (26%)     48 (96%)     49 (98%)                               
      Inflammation, Chronic, Focal                     1 (2%)       2 (4%)      11 (22%)     18 (36%)                               
      Inflammation, Focal, Suppurative                                           2 (4%)      14 (28%)                               
      Alveolar Epithelium, Hyperplasia                 2 (4%)       5 (10%)     27 (54%)     43 (86%)                               
      Alveolus, Foreign Body                                        8 (16%)     48 (96%)     49 (98%)                               
      Alveolus, Proteinosis                                         4 (8%)      49 (98%)     50 (100%)                              

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05180-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          GALLIUM ARSENIDE                                     Date: 03/09/99  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 14:17:25  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        CONTROL      0.1          0.5          1.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Mediastinum, Necrosis                                         1 (2%)                                                          
      Perivascular, Infiltration Cellular,                                                                                          
          Mononuclear Cell                             2 (4%)                    2 (4%)       2 (4%)                                
   Nose                                               (50)         (49)         (50)         (50)                                   
      Inflammation, Suppurative                        2 (4%)                    4 (8%)       4 (8%)                                
      Olfactory Epithelium, Atrophy                    3 (6%)       1 (2%)       7 (14%)      4 (8%)                                
      Olfactory Epithelium, Degeneration, Hyaline      3 (6%)       1 (2%)      10 (20%)      5 (10%)                               
      Olfactory Epithelium, Inflammation, Chronic                                1 (2%)                                             
      Olfactory Epithelium, Metaplasia, Respiratory                              1 (2%)       1 (2%)                                
      Respiratory Epithelium, Degeneration, Hyaline   15 (30%)     17 (35%)     21 (42%)     17 (34%)                               
      Respiratory Epithelium, Metaplasia, Squamous                               2 (4%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (1)                       (2)          (1)                                    
      Degeneration                                                               1 (50%)                                            
      Cornea, Inflammation, Chronic                    1 (100%)                  1 (50%)      1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Glomerulosclerosis                               2 (4%)                                                                       
      Hydronephrosis                                   1 (2%)                                                                       
      Inflammation, Chronic Active                                                            1 (2%)                                
      Metaplasia, Osseous                              2 (4%)       3 (6%)       1 (2%)       1 (2%)                                
      Nephropathy                                     43 (86%)     44 (88%)     40 (80%)     36 (72%)                               
      Capsule, Inflammation                                                                   1 (2%)                                
      Renal Tubule, Hyperplasia                                                               1 (2%)                                
   Urinary Bladder                                    (48)         (48)         (50)         (48)                                   
      Angiectasis                                      1 (2%)                                                                       
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
      Artery, Inflammation                                                       1 (2%)                                             
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05180-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          GALLIUM ARSENIDE                                     Date: 03/09/99  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 14:17:25  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          CONTROL      0.1          0.5          1.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 


  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                 7            8           10            7                                     
    Natural Death                                      8            4            6            9                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                35           38           34           34                                     

  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (42)         (47)         (41)         (43)                                   
      Degeneration, Hyaline                                         1 (2%)                    1 (2%)                                
   Intestine Small, Jejunum                           (44)         (48)         (45)         (43)                                   
      Peyer's Patch, Hyperplasia                       1 (2%)                    1 (2%)       1 (2%)                                
   Intestine Small, Ileum                             (44)         (47)         (45)         (42)                                   
      Peyer's Patch, Hyperplasia                                                 1 (2%)                                             
   Liver                                              (50)         (50)         (50)         (50)                                   
      Basophilic Focus                                              1 (2%)       2 (4%)       2 (4%)                                
      Clear Cell Focus                                              2 (4%)       2 (4%)       1 (2%)                                
      Degeneration, Fatty                              1 (2%)       1 (2%)       1 (2%)                                             
      Eosinophilic Focus                               8 (16%)     12 (24%)     11 (22%)     14 (28%)                               
      Eosinophilic Focus, Multiple                     3 (6%)       2 (4%)       3 (6%)       5 (10%)                               
      Hematopoietic Cell Proliferation                 3 (6%)       1 (2%)       2 (4%)       2 (4%)                                
      Inflammation                                     2 (4%)       3 (6%)       1 (2%)                                             
      Necrosis                                        10 (20%)      6 (12%)      5 (10%)      4 (8%)                                
      Bile Duct, Cyst                                  1 (2%)                    1 (2%)                                             
      Oval Cell, Hyperplasia                           1 (2%)       1 (2%)                                                          
   Mesentery                                          (4)          (5)          (4)          (6)                                    
      Fat, Necrosis                                    1 (25%)      5 (100%)     3 (75%)      6 (100%)                              
   Pancreas                                           (50)         (50)         (49)         (47)                                   
      Atrophy                                         13 (26%)      7 (14%)      9 (18%)      6 (13%)                               
      Inflammation                                     1 (2%)                                                                       
   Stomach, Forestomach                               (50)         (50)         (49)         (49)                                   
      Ulcer                                            2 (4%)                                 1 (2%)                                
      Epithelium, Hyperplasia                          6 (12%)      2 (4%)       3 (6%)       3 (6%)                                
   Stomach, Glandular                                 (49)         (50)         (49)         (48)                                   
      Infiltration Cellular, Mixed Cell                             1 (2%)                                                          
      Ulcer                                                                                   1 (2%)                                
   Tooth                                              (1)          (3)          (1)          (1)                                    
      Malformation                                     1 (100%)     2 (67%)      1 (100%)     1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05180-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          GALLIUM ARSENIDE                                     Date: 03/09/99  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 14:17:25  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          CONTROL      0.1          0.5          1.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                  48 (96%)     50 (100%)    49 (98%)     47 (94%)                               
      Thrombosis                                                    1 (2%)                                                          
      Artery, Inflammation                                                       1 (2%)                                             
      Atrium, Thrombosis                               2 (4%)                                                                       
      Ventricle, Thrombosis                                                      1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (48)                                   
      Degeneration, Cystic                                                                    1 (2%)                                
      Hyperplasia                                      4 (8%)      10 (20%)      7 (14%)      4 (8%)                                
      Hypertrophy                                     38 (76%)     33 (66%)     38 (76%)     30 (63%)                               
      Mineralization                                                             1 (2%)                                             
   Adrenal Medulla                                    (50)         (50)         (50)         (47)                                   
      Hyperplasia                                                                             1 (2%)                                
   Islets, Pancreatic                                 (50)         (48)         (49)         (47)                                   
      Hyperplasia                                      2 (4%)       3 (6%)       2 (4%)       4 (9%)                                
   Pituitary Gland                                    (48)         (48)         (47)         (47)                                   
      Pars Distalis, Hyperplasia                                    1 (2%)       1 (2%)       1 (2%)                                
   Thyroid Gland                                      (50)         (50)         (50)         (48)                                   
      Follicular Cell, Hyperplasia                    11 (22%)     13 (26%)      7 (14%)      8 (17%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (50)         (50)         (50)         (49)                                   
      Granuloma Sperm                                               2 (4%)                    1 (2%)                                
      Hyperplasia                                      1 (2%)       1 (2%)                                                          
      Inflammation                                     2 (4%)       1 (2%)                                                          
   Preputial Gland                                    (50)         (49)         (49)         (48)                                   
      Ectasia                                          5 (10%)      3 (6%)       5 (10%)      5 (10%)                               
      Inflammation                                     3 (6%)       3 (6%)       4 (8%)       9 (19%)                               
   Prostate                                           (50)         (49)         (49)         (49)                                   
      Inflammation                                     2 (4%)                    1 (2%)       1 (2%)                                
   Seminal Vesicle                                    (50)         (50)         (48)         (43)                                   
      Inflammation                                                  1 (2%)                    1 (2%)                                
   Testes                                             (50)         (50)         (50)         (50)                                   
      Atrophy                                          6 (12%)      9 (18%)      2 (4%)       2 (4%)                                
____________________________________________________________________________________________________________________________________

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05180-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          GALLIUM ARSENIDE                                     Date: 03/09/99  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 14:17:25  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          CONTROL      0.1          0.5          1.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (49)         (50)         (50)         (48)                                   
      Hyperplasia                                      2 (4%)       3 (6%)       2 (4%)       3 (6%)                                
   Lymph Node                                         (2)                       (2)          (1)                                    
      Hyperplasia                                      1 (50%)                                                                      
   Lymph Node, Bronchial                              (38)         (37)         (40)         (41)                                   
      Hyperplasia                                      5 (13%)      7 (19%)     17 (43%)     24 (59%)                               
   Lymph Node, Mandibular                             (37)         (40)         (28)         (32)                                   
      Hyperplasia                                      2 (5%)       3 (8%)                                                          
   Lymph Node, Mesenteric                             (48)         (49)         (50)         (46)                                   
      Angiectasis                                                   1 (2%)       1 (2%)       1 (2%)                                
      Erythrophagocytosis                                           1 (2%)                                                          
      Hematopoietic Cell Proliferation                 1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
      Hyperplasia                                      3 (6%)       5 (10%)      4 (8%)       4 (9%)                                
   Lymph Node, Mediastinal                            (38)         (36)         (38)         (33)                                   
      Hematopoietic Cell Proliferation                              1 (3%)                                                          
      Hyperplasia                                      1 (3%)       1 (3%)       4 (11%)      3 (9%)                                
   Spleen                                             (50)         (50)         (49)         (47)                                   
      Hematopoietic Cell Proliferation                17 (34%)     13 (26%)     19 (39%)     18 (38%)                               
      Hyperplasia, Lymphoid                            1 (2%)       5 (10%)      3 (6%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (50)         (50)         (50)         (50)                                   
      Cyst Epithelial Inclusion                                                  1 (2%)                                             
      Inflammation                                     1 (2%)                                 1 (2%)                                
      Prepuce, Inflammation, Chronic Active            2 (4%)       4 (8%)       3 (6%)       3 (6%)                                
      Subcutaneous Tissue, Inflammation, Chronic                                 2 (4%)                                             
      Subcutaneous Tissue, Inflammation, Focal,                                                                                     
           Suppurative                                              1 (2%)                                                          
      Subcutaneous Tissue, Inflammation,                                                                                            
          Granulomatous                                1 (2%)       1 (2%)                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (49)         (50)         (50)         (50)                                   
      Fibrous Osteodystrophy                           1 (2%)       2 (4%)       2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05180-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          GALLIUM ARSENIDE                                     Date: 03/09/99  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 14:17:25  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          CONTROL      0.1          0.5          1.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (49)                                   
      Meninges, Infiltration Cellular, Mononuclear                                                                                  
          Cell                                                                   1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (50)         (50)         (48)         (48)                                   
      Inflammation, Suppurative                                     1 (2%)       1 (2%)                                             
      Metaplasia, Squamous                             1 (2%)                                                                       
      Squamous Epithelium, Hyperplasia                11 (22%)     13 (26%)     11 (23%)      5 (10%)                               
   Lung                                               (50)         (50)         (50)         (50)                                   
      Congestion                                       1 (2%)                                                                       
      Hematopoietic Cell Proliferation                                           1 (2%)       1 (2%)                                
      Hemorrhage                                       5 (10%)      6 (12%)      6 (12%)      3 (6%)                                
      Hyperplasia, Atypical                                                                   1 (2%)                                
      Infiltration Cellular, Histiocyte                3 (6%)      10 (20%)     45 (90%)     48 (96%)                               
      Inflammation, Chronic, Focal                     1 (2%)       3 (6%)       3 (6%)      12 (24%)                               
      Inflammation, Focal, Suppurative                                           8 (16%)     23 (46%)                               
      Alveolar Epithelium, Hyperplasia                 4 (8%)       9 (18%)     39 (78%)     45 (90%)                               
      Alveolus, Foreign Body                                        4 (8%)      46 (92%)     50 (100%)                              
      Alveolus, Proteinosis                            1 (2%)       4 (8%)      49 (98%)     50 (100%)                              
   Nose                                               (49)         (49)         (49)         (48)                                   
      Inflammation, Suppurative                                     3 (6%)       2 (4%)       1 (2%)                                
      Olfactory Epithelium, Atrophy                    7 (14%)      2 (4%)       5 (10%)      8 (17%)                               
      Olfactory Epithelium, Degeneration, Hyaline      2 (4%)       4 (8%)       6 (12%)      1 (2%)                                
      Respiratory Epithelium, Degeneration, Hyaline    1 (2%)       2 (4%)       2 (4%)       1 (2%)                                
      Respiratory Epithelium, Hyperplasia                           1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (2)          (1)                       (4)                                    
      Degeneration                                                  1 (100%)                  2 (50%)                               
      Cornea, Inflammation, Chronic                    1 (50%)                                                                      
   Harderian Gland                                    (47)         (48)         (49)         (48)                                   
      Hyperplasia                                      1 (2%)       1 (2%)      10 (20%)      1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (49)         (48)                                   
      Cyst                                             1 (2%)                                                                       
      Hydronephrosis                                   2 (4%)       3 (6%)       2 (4%)       3 (6%)                                
      Infarct                                                       1 (2%)                                                          
      Inflammation, Chronic Active                     1 (2%)                    1 (2%)       1 (2%)                                

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 05180-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          GALLIUM ARSENIDE                                     Date: 03/09/99  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 14:17:25  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          CONTROL      0.1          0.5          1.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Metaplasia, Osseous                                           1 (2%)       4 (8%)                                             
      Nephropathy                                     48 (96%)     49 (98%)     45 (92%)     47 (98%)                               
      Capsule, Inflammation                                         1 (2%)       2 (4%)                                             
      Cortex, Cyst                                     2 (4%)       4 (8%)                    2 (4%)                                
      Renal Tubule, Hyperplasia                        2 (4%)                    3 (6%)       1 (2%)                                
      Renal Tubule, Necrosis                                                     1 (2%)                                             
   Urinary Bladder                                    (49)         (50)         (46)         (46)                                   
      Inflammation                                     1 (2%)                                 2 (4%)                                
      Transitional Epithelium, Hyperplasia             1 (2%)                                                                       
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------